Acorai is pleased to announce the enrolment of its first patient in the 1000-patient HOSP-HF study (Hemodynamic Observational Study in Patients with Heart Failure using a Non-Invasive Multi-Modal Sensing Device).
This multi-site observational study will evaluate whether objective, non-invasive congestion assessment during hospitalization and near discharge is associated with 30-day outcomes in decompensated heart failure patients. The study will run across ten centers in Europe, Asia and the United States during 2026.
Residual congestion at discharge is recognized as a key driver of early deterioration after heart failure hospitalization. Yet in routine practice, discharge-readiness assessment can be inconsistent and uncertain, relying on a combination of physical examination, natriuretic peptides, daily weight, imaging, and clinical judgment that does not adequately capture hemodynamic change.